Skip to main content
Top
Published in: World Journal of Surgery 12/2020

01-12-2020 | Computed Tomography | Original Scientific Report

Diffusion-Weighted MRI Predicts Lymph Node Metastasis and Tumor Aggressiveness in Resectable Pancreatic Neuroendocrine Tumors

Authors: Norifumi Harimoto, Kenichiro Araki, Kouki Hoshino, Ryo Muranushi, Kei Hagiwara, Norihiro Ishii, Mariko Tsukagoshi, Takamichi Igarashi, Akira Watanabe, Norio Kubo, Hiroyasu Tomonaga, Tetsuya Higuchi, Yoshito Tsushima, Hayato Ikota, Ken Shirabe

Published in: World Journal of Surgery | Issue 12/2020

Login to get access

Abstract

Objectives

The aim of this study was to identify whether diffusion-weighted magnetic resonance imaging (DW-MRI) can predict the malignant behavior of preoperative well-differentiated pancreatic neuroendocrine tumors (PanNETs).

Method

Forty patients with PanNETs who underwent pancreatectomy were enrolled in this study. The apparent diffusion coefficient (ADC) values were measured. Clinicopathological factors were compared in patients with high ADC and low ADC values and in patients with and without lymph node metastasis (LNM).

Result

The low ADC group was significantly associated with higher Ki-67 index, higher mitotic count, larger tumor size, higher rate of LNM, and venous invasion. In patients with low ADC values, the incidence of LNMs was 33.3%. In patients with high ADC values, there were no patients with LNM being 0%. A significant negative correlation was found between the mean ADC values and the Ki-67 index and between the mean ADC values and the mitotic count. In multivariate analysis, neural invasion and mean ADC values ≤ 1458 were independent predictors of LNM.

Conclusion

ADC values obtained using DW-MRI in the preoperative assessment of patients with PanNETs might be a useful predictor of malignant potential, especially LNM.
Literature
1.
go back to reference Fesinmeyer MD, Austin MA, Li CI, De Roos AJ et al (2005) Differences in survival by histologic type of pancreatic cancer. Cancer Epidemiol Biomark Prev 14:1766–1773CrossRef Fesinmeyer MD, Austin MA, Li CI, De Roos AJ et al (2005) Differences in survival by histologic type of pancreatic cancer. Cancer Epidemiol Biomark Prev 14:1766–1773CrossRef
2.
go back to reference Yao JC, Hassan M, Phan A et al (2008) One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 26:3063–3072CrossRef Yao JC, Hassan M, Phan A et al (2008) One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 26:3063–3072CrossRef
3.
go back to reference Bosman FT, Carneiro F, Hruban RH et al (2010) WHO classification of tumours of the digestive system, 4th edn. International Agency for Research on Cancer, Lyon Bosman FT, Carneiro F, Hruban RH et al (2010) WHO classification of tumours of the digestive system, 4th edn. International Agency for Research on Cancer, Lyon
4.
go back to reference Lloyd RV, Osamura RY, Klöppel G et al (2017) WHO classification of tumours of endocrine organs, 4th edn. International Agency for Research on Cancer, Lyon, p 355 Lloyd RV, Osamura RY, Klöppel G et al (2017) WHO classification of tumours of endocrine organs, 4th edn. International Agency for Research on Cancer, Lyon, p 355
5.
go back to reference Harimoto N, Hoshino K, Muranushi R et al (2019) Significance of lymph node metastasis in resectable well-differentiated pancreatic neuroendocrine tumor. Pancreas 48(7):943–947CrossRef Harimoto N, Hoshino K, Muranushi R et al (2019) Significance of lymph node metastasis in resectable well-differentiated pancreatic neuroendocrine tumor. Pancreas 48(7):943–947CrossRef
6.
go back to reference Harimoto N, Hoshino K, Muranushi R et al (2019) Prognostic significance of neutrophil-lymphocyte ratio in resectable pancreatic neuroendocrine tumors with special reference to tumor-associated macrophages. Pancreatol 19(6):897–902CrossRef Harimoto N, Hoshino K, Muranushi R et al (2019) Prognostic significance of neutrophil-lymphocyte ratio in resectable pancreatic neuroendocrine tumors with special reference to tumor-associated macrophages. Pancreatol 19(6):897–902CrossRef
7.
go back to reference Weynand B, Borbath I, Bernard V et al (2014) Pancreatic neuroendocrine tumour grading on endoscopic ultrasound-guided fine needle aspiration: high reproducibility and inter-observer agreement of the Ki-67 labelling index. Cytopathol 25:389–395 Weynand B, Borbath I, Bernard V et al (2014) Pancreatic neuroendocrine tumour grading on endoscopic ultrasound-guided fine needle aspiration: high reproducibility and inter-observer agreement of the Ki-67 labelling index. Cytopathol 25:389–395
8.
go back to reference Fujimori N, Osoegawa T, Lee L et al (2016) Efficacy of endoscopic ultrasonography and endoscopic ultrasonography-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors. Scand J Gastroenterol 51(2):245–252CrossRef Fujimori N, Osoegawa T, Lee L et al (2016) Efficacy of endoscopic ultrasonography and endoscopic ultrasonography-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors. Scand J Gastroenterol 51(2):245–252CrossRef
9.
go back to reference Sugimoto M, Takagi T, Hikichi T et al (2015) Efficacy of endoscopic ultrasonography-guided fine needle aspiration for pancreatic neuroendocrine tumor grading. World J Gastroenterol 21(26):8118–8124CrossRef Sugimoto M, Takagi T, Hikichi T et al (2015) Efficacy of endoscopic ultrasonography-guided fine needle aspiration for pancreatic neuroendocrine tumor grading. World J Gastroenterol 21(26):8118–8124CrossRef
10.
go back to reference Garces-Descovich A, Morrison TC, Beker K et al (2019) DWI of pancreatic ductal adenocarcinoma: a pilot study to estimate the correlation with metastatic disease potential and overall survival. AJR Am J Roentgenol 212(2):323–331CrossRef Garces-Descovich A, Morrison TC, Beker K et al (2019) DWI of pancreatic ductal adenocarcinoma: a pilot study to estimate the correlation with metastatic disease potential and overall survival. AJR Am J Roentgenol 212(2):323–331CrossRef
11.
go back to reference Yamada S, Morine Y, Imura S, et al (2020) Prognostic prediction of apparent diffusion coefficient obtained by diffusion-weighted MRI in mass-forming intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Sci 27(7):388–395 Yamada S, Morine Y, Imura S, et al (2020) Prognostic prediction of apparent diffusion coefficient obtained by diffusion-weighted MRI in mass-forming intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Sci 27(7):388–395
12.
go back to reference Schmeel FC, Simon B, Luetkens JA et al (2017) Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization. J Cancer Res Clin Oncol 143(8):1531–1541CrossRef Schmeel FC, Simon B, Luetkens JA et al (2017) Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization. J Cancer Res Clin Oncol 143(8):1531–1541CrossRef
13.
go back to reference Kitajima K, Yamano T, Fukushima K et al (2016) Correlation of the SUVmax of FDG-PET and ADC values of diffusion-weighted MR imaging with pathologic prognostic factors in breast carcinoma. Eur J Radiol 85(5):943–949CrossRef Kitajima K, Yamano T, Fukushima K et al (2016) Correlation of the SUVmax of FDG-PET and ADC values of diffusion-weighted MR imaging with pathologic prognostic factors in breast carcinoma. Eur J Radiol 85(5):943–949CrossRef
14.
go back to reference Zong RL, Geng L, Wang X et al (2019) Diagnostic performance of apparent diffusion coefficient for prediction of grading of pancreatic neuroendocrine tumors: a systematic review and meta-analysis. Pancreas 48(2):151–160CrossRef Zong RL, Geng L, Wang X et al (2019) Diagnostic performance of apparent diffusion coefficient for prediction of grading of pancreatic neuroendocrine tumors: a systematic review and meta-analysis. Pancreas 48(2):151–160CrossRef
15.
go back to reference Paudyal B, Paudyal P, Tsushima Y et al (2010) The role of the ADC value in the characterisation of renal carcinoma by diffusion-weighted MRI. Br J Radiol 83(988):336–343CrossRef Paudyal B, Paudyal P, Tsushima Y et al (2010) The role of the ADC value in the characterisation of renal carcinoma by diffusion-weighted MRI. Br J Radiol 83(988):336–343CrossRef
16.
go back to reference Tsushima Y, Takahashi-Taketomi A, Endo K (2009) Magnetic resonance (MR) differential diagnosis of breast tumors using apparent diffusion coefficient (ADC) on 1.5-T. J Magn Reson Imaging 30(2):249–255CrossRef Tsushima Y, Takahashi-Taketomi A, Endo K (2009) Magnetic resonance (MR) differential diagnosis of breast tumors using apparent diffusion coefficient (ADC) on 1.5-T. J Magn Reson Imaging 30(2):249–255CrossRef
17.
go back to reference Hu Y, Rao S, Xu X et al (2018) Grade 2 pancreatic neuroendocrine tumors: overbroad scope of Ki-67 index according to MRI features. Abdom Radiol (NY) 43(11):3016–3024CrossRef Hu Y, Rao S, Xu X et al (2018) Grade 2 pancreatic neuroendocrine tumors: overbroad scope of Ki-67 index according to MRI features. Abdom Radiol (NY) 43(11):3016–3024CrossRef
18.
go back to reference De Robertis R, Maris B, Cardobi N et al (2018) Can histogram analysis of MR images predict aggressiveness in pancreatic neuroendocrine tumors? Eur Radiol 28(6):2582–2591CrossRef De Robertis R, Maris B, Cardobi N et al (2018) Can histogram analysis of MR images predict aggressiveness in pancreatic neuroendocrine tumors? Eur Radiol 28(6):2582–2591CrossRef
19.
go back to reference Guo C, Zhuge X, Chen X et al (2017) Value of diffusion-weighted magnetic resonance imaging in predicting World Health Organization grade in G1/G2 pancreatic neuroendocrine tumors. Oncol Lett 13(6):4141–4146CrossRef Guo C, Zhuge X, Chen X et al (2017) Value of diffusion-weighted magnetic resonance imaging in predicting World Health Organization grade in G1/G2 pancreatic neuroendocrine tumors. Oncol Lett 13(6):4141–4146CrossRef
20.
go back to reference Lotfalizadeh E, Ronot M, Wagner M et al (2017) Prediction of pancreatic neuroendocrine tumour grade with MR imaging features: added value of diffusion-weighted imaging. Eur Radiol 27(4):1748–1759CrossRef Lotfalizadeh E, Ronot M, Wagner M et al (2017) Prediction of pancreatic neuroendocrine tumour grade with MR imaging features: added value of diffusion-weighted imaging. Eur Radiol 27(4):1748–1759CrossRef
21.
go back to reference Pereira JA, Rosado E, Bali M et al (2015) Pancreatic neuroendocrine tumors: correlation between histogram analysis of apparent diffusion coefficient maps and tumor grade. Abdom Imaging 40(8):3122–3128CrossRef Pereira JA, Rosado E, Bali M et al (2015) Pancreatic neuroendocrine tumors: correlation between histogram analysis of apparent diffusion coefficient maps and tumor grade. Abdom Imaging 40(8):3122–3128CrossRef
22.
go back to reference Sun HT, Zhang SL, Liu K, Zhou JJ et al (2019) MRI-based nomogram estimates the risk of recurrence of primary nonmetastatic pancreatic neuroendocrine tumors after curative resection. J Magn Reson Imaging 50(2):397–409CrossRef Sun HT, Zhang SL, Liu K, Zhou JJ et al (2019) MRI-based nomogram estimates the risk of recurrence of primary nonmetastatic pancreatic neuroendocrine tumors after curative resection. J Magn Reson Imaging 50(2):397–409CrossRef
23.
go back to reference Yamamoto Y, Okamura Y, Uemura S et al (2017) Vascularity and tumor size are significant predictors for recurrence after resection of a pancreatic neuroendocrine tumor. Ann Surg Oncol 24(8):2363–2370CrossRef Yamamoto Y, Okamura Y, Uemura S et al (2017) Vascularity and tumor size are significant predictors for recurrence after resection of a pancreatic neuroendocrine tumor. Ann Surg Oncol 24(8):2363–2370CrossRef
24.
go back to reference Okabe H, Hashimoto D, Chikamoto A et al (2017) Shape and enhancement characteristics of pancreatic neuroendocrine tumor on preoperative contrast-enhanced computed tomography may be prognostic indicators. Ann Surg Oncol 24(5):1399–1405CrossRef Okabe H, Hashimoto D, Chikamoto A et al (2017) Shape and enhancement characteristics of pancreatic neuroendocrine tumor on preoperative contrast-enhanced computed tomography may be prognostic indicators. Ann Surg Oncol 24(5):1399–1405CrossRef
25.
go back to reference Hashim YM, Trinkaus KM, Linehan DC et al (2014) Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs). Ann Surg 259:197–203CrossRef Hashim YM, Trinkaus KM, Linehan DC et al (2014) Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs). Ann Surg 259:197–203CrossRef
26.
go back to reference Falconi M, Eriksson B, Kaltsas G et al (2016) ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors. Neuroendocrinol 103:153–171CrossRef Falconi M, Eriksson B, Kaltsas G et al (2016) ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors. Neuroendocrinol 103:153–171CrossRef
27.
go back to reference Oberg K, Knigge U, Kwekkeboom D et al (2012) ESMO guidelines working group neuroendocrine gastro-entero-pancreatic tumors: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 23:124–130CrossRef Oberg K, Knigge U, Kwekkeboom D et al (2012) ESMO guidelines working group neuroendocrine gastro-entero-pancreatic tumors: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 23:124–130CrossRef
28.
go back to reference Conrad C, Kutlu OC, Dasari A et al (2016) Prognostic value of lymph node status and extent of lymphadenectomy in pancreatic neuroendocrine tumors confined to and extending beyond the pancreas. J Gastrointest Surg 20:1966–1974CrossRef Conrad C, Kutlu OC, Dasari A et al (2016) Prognostic value of lymph node status and extent of lymphadenectomy in pancreatic neuroendocrine tumors confined to and extending beyond the pancreas. J Gastrointest Surg 20:1966–1974CrossRef
29.
go back to reference Chouliaras K, Newman NA, Shukla M et al (2018) Analysis of recurrence after the resection of pancreatic neuroendocrine tumors. J Surg Oncol 118:416–421CrossRef Chouliaras K, Newman NA, Shukla M et al (2018) Analysis of recurrence after the resection of pancreatic neuroendocrine tumors. J Surg Oncol 118:416–421CrossRef
30.
go back to reference Bilimoria KY, Talamonti MS, Tomlinson JS et al (2008) Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients. Ann Surg 247:490–500CrossRef Bilimoria KY, Talamonti MS, Tomlinson JS et al (2008) Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients. Ann Surg 247:490–500CrossRef
31.
go back to reference Sallinen VJ, Le Large TYS, Tieftrunk E et al (2018) Prognosis of sporadic resected small (≤2 cm) nonfunctional pancreatic neuroendocrine tumors: a multi-institutional study. HPB 20:251–259CrossRef Sallinen VJ, Le Large TYS, Tieftrunk E et al (2018) Prognosis of sporadic resected small (≤2 cm) nonfunctional pancreatic neuroendocrine tumors: a multi-institutional study. HPB 20:251–259CrossRef
32.
go back to reference Fischer L, Bergmann F, Schimmack S et al (2014) Outcome of surgery for pancreatic neuroendocrine neoplasms. Br J Surg 101:1405–1412CrossRef Fischer L, Bergmann F, Schimmack S et al (2014) Outcome of surgery for pancreatic neuroendocrine neoplasms. Br J Surg 101:1405–1412CrossRef
33.
go back to reference Tsutsumi K, Ohtsuka T, Fujino M et al (2014) Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification. J Hepatobiliary Pancreat Sci 21:418–425CrossRef Tsutsumi K, Ohtsuka T, Fujino M et al (2014) Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification. J Hepatobiliary Pancreat Sci 21:418–425CrossRef
34.
go back to reference Wong J, Fulp WJ, Strosberg JR et al (2014) Predictors of lymph node metastases and impact on survival in resected pancreatic neuroendocrine tumors: a single-center experience. Am J Surg 208:775–780CrossRef Wong J, Fulp WJ, Strosberg JR et al (2014) Predictors of lymph node metastases and impact on survival in resected pancreatic neuroendocrine tumors: a single-center experience. Am J Surg 208:775–780CrossRef
Metadata
Title
Diffusion-Weighted MRI Predicts Lymph Node Metastasis and Tumor Aggressiveness in Resectable Pancreatic Neuroendocrine Tumors
Authors
Norifumi Harimoto
Kenichiro Araki
Kouki Hoshino
Ryo Muranushi
Kei Hagiwara
Norihiro Ishii
Mariko Tsukagoshi
Takamichi Igarashi
Akira Watanabe
Norio Kubo
Hiroyasu Tomonaga
Tetsuya Higuchi
Yoshito Tsushima
Hayato Ikota
Ken Shirabe
Publication date
01-12-2020
Publisher
Springer International Publishing
Published in
World Journal of Surgery / Issue 12/2020
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-020-05736-3

Other articles of this Issue 12/2020

World Journal of Surgery 12/2020 Go to the issue